Clinical Evidence & Publication

Explore the scientific research behind our probiotic strains and their potential health benefits with our curated collection of clinical evidence and publications.

Jugan, et. al Probiotic may help support...GI health during chemo 2021

Read the Article

Ziese et al. Effect of probiotic treatment..., PLoS ONE 2018.

Read the Abstract

White et al. Randomized, controlled trial evaluating the effect ofmulti-strain probiotic..., Gut Microbes. 2017.

Read the Abstract

Rossi et al. Effects of probiotic bacteria..., Beneficial Microbes. 2017

Read the Abstract

Lippi et al. Effects of probiotic.., Canadian Veterinary Journal 2017.

Read the Abstract

Rossi et al. Comparison of Microbiological, Histological, andImmunomodulatory Parameters..., PloS ONE 201

Read the Abstract

Arslan et al, Therapeutic effects of probiotic bacteria in Parvoviral …,Ondokuz Mayis University, 2012

Read the Abstract

Rossi et al., Effects of a probiotic (SLAB51®) on clinical and histologic variables ... Beneficial Microbes. 2017

Read the Abstract
 

Jugan, et. al Probiotic may help support...GI health during chemo 2021

Read the Article

Ziese et al. Effect of probiotic treatment..., PLoS ONE 2018.

Read the Abstract

White et al. Randomized, controlled trial evaluating the effect ofmulti-strain probiotic..., Gut Microbes. 2017.

Read the Abstract

Rossi et al. Effects of probiotic bacteria..., Beneficial Microbes. 2017

Read the Abstract

Lippi et al. Effects of probiotic.., Canadian Veterinary Journal 2017.

Read the Abstract

Rossi et al. Comparison of Microbiological, Histological, andImmunomodulatory Parameters..., PloS ONE 201

Read the Abstract

Arslan et al, Therapeutic effects of probiotic bacteria in Parvoviral …,Ondokuz Mayis University, 2012

Read the Abstract

Rossi et al., Effects of a probiotic (SLAB51®) on clinical and histologic variables ... Beneficial Microbes. 2017

Read the Abstract

Clinical Development Pipeline

ExeGi Pharma, The makers of Visbiome Vet is focused on research and development of microbiome science and expanding the use of the De Simone Formulation contained in Visbiome® Vet in a variety of therapeutic areas. ExeGi Pharma currently has five clinical trials ongoing in additional gastrointestinal conditions of both dogs and cats.

  • Dogs
    Cats

    Study Design

    Canine Esomeprazole/Probiotic study (effect of probiotic admin. on fecal dysbiosis and intestinal inflam. Secondary to Esomeprazole admin in healthy dogs)

  • Dogs
    Cats

    Study Design

    Effect of probiotic on seizure frequency and microbiome in idiopathic epilepsy receiving anti-epileptic drugs

  • Cats

    Study Design

    Chronic Kidney Disease in Cats. Reduction of serum indoxyl sulfate concentration and preservation of renal function

  • Dogs
    Cats

    Study Design

    HE clinical signs and blood ammonia levels

Interested In Conducting Studies With Visbiome Vet?

Fill Form